Stay Ahead in Fast-Growing Economies.
Browse Reports Now
Personalized Genomics Market Size, Share, Growth & Forecast (2024-2032)
Personalized Genomics Market Size Was Valued at USD 9.25 Billion in 2023, and is Projected to Reach USD 27.90 Billion by 2032, Growing at a CAGR of 17.19% From 2024-2032.
IMR Group
Description
Personalized Genomics Market Synopsis:
Personalized Genomics Market Size Was Valued at USD 9.25 Billion in 2023, and is Projected to Reach USD 27.90 Billion by 2032, Growing at a CAGR of 17.19% From 2024-2032.
The Personalized Genomics Market has specialized in the tailored medical treatment that reflects the patient’s genetic profile. This market has gained much attention as the turn around of genomic sequencing has become easier and cheaper to implement. Personalized genomics refers to the development of customized medical interventions to treat and prevent diseases, and the individual requirement of the patients in question is considered. It refines treatments and outcomes in overall and especially in cancer, heart disease, and genetic disorders, among specialist treatment areas.
The leading factor expected to fuel the growth of the Personalized Genomics Market is the rising knowledge and endorsement of precision medication that focuses on genes in disease diagnosis and treatment. In this way, there is a growing trend for investment in research and development in health care providers and patients to improve and enhance the wider application of genomic information. In recent years, efforts toward the adoption of genomics as a standard practice in health care are increasing, thereby driving the market. It is also enables by the rising acceptance of consumer based genetic testing service that drive the growth of the market as people look for information on their inherited genes and risks.
Nevertheless, the market has issues; ethical issues of genetic data, discrimination based on genetic data, and the question of the legal frameworks that govern the use of genomic data. However, these challenges do not deter the opportunities available in the Personalized Genomics Market as constant growth in artificial intelligence and bioinformatics and an increased academic-Industry tie-up between various academic establishments and Biotechnology industries worldwide. While it is still a relatively young field, the future use of personalized genomics to transform the way healthcare is delivered and improve patient outcomes is promising, confidently placing personalized genomics in the center of the future of medicine.
Personalized Genomics Market Trend Analysis:
Growing Adoption of Direct-to-Consumer Genetic Testing
Another important rising trend in the Personalized Genomics Market is the emergence of Direct-to-Consumer (DTC) genetic testing services. These services help people to get their DNA reports anytime without any doctor’s prescription and know about their ancestry, risks for diseases and genetic tendency towards some diseases.
Many other self-testing services have followed the example of 23andMe and AncestryDNA and put health in the hands of the consumer. The increased popularity of DTC testing is also bringing more attention to people and creating a demand for personal genomics and targeted healthcare approaches while also inspiring further advancements in genetic studies as well as genetic interpretation.
Integration of Artificial Intelligence in Genomic Research
The fourth and another progressive teaching is the use of artificial intelligence and machine learning in genomics research and analysis. These advanced technologies are being applied in small tasks to improve data manageability to support better interpretation of complicated genomic information.
The results reveal that AI algorithms can define patterns or relations between big datasets and then design individual treatment strategies for patients and estimate the probable response of the body to therapies and medication. AI has a bright future and as the technology develops its applicability to the Personalized Genomics Market is expected to rise and expand the potential of advanced health care and precision medicine based on a patient’s personal genetic background.
Personalized Genomics Market Segment Analysis:
Personalized Genomics Market is Segmented on the basis of Test Type, Technology, Application, End User, and Region.
By Test Type, Oncology Testing segment is expected to dominate the market during the forecast period
Based on the type of tests: oncology testing, infectious disease testing, neurological testing, cardiovascular testing, and others constitute the Personalized Genomics Market. Oncology testing is well established, benefiting from the rising trend of precision medicine in the management of cancer through genome information for definite mutational changes and the consequent treatment options. Diagnostic testing has assumed significance because of the need for accurate and fast results specifically in chronic diseases as well as emerging epidemics and pandemics.
One of the rapidly growing areas is neurological testing because the ability to analyse genetic preconditions can help identify and address issues with neurodegenerative diseases. Genomic based cardiovascular testing mainly focuses on determining potential risk in individual to avoid cardiac risks and deficiency. The “other” group consists of many applications, which represents an extensive role of personalized genomics in improving the healthcare system based on different medicine branches. This segmentation demonstrates increasing credence of genetics in diagnostic and therapeutic approaches, subsequently fostering advances in individualized genomic solutions.
By Application, Diagnostics segment expected to held the largest share
The market is broadly categorized based on application into diagnostics, precision medicine, wellness, reproductive health, sports nutrition and healthy lifestyle and Others. In diagnostics, personalized genomics is applied to find the presence of other genetic disorders and to design unique treatment regimes with the help of a patient’s genetic makeup. Precision medicine takes advantage of genomic data to design special treatments that increase treatment outcome of illnesses for example cancer.
The wellness segment is aimed at informing the population on issues of their genetic makeup most closely connected with health and lifestyles in the area of diet and exercise, and accordingly, providing them with instructions on what courses of action are appropriate in their particular cases. Applications of Reproductive health include genetic risk profiling in family planning and prenatal diagnosis. Moreover, the augmented genetic profiling has become useful across the sports nutrition and health lifestyle sector through a genetic point of view to enhance the performance of athletes or customize fitness regimes. In general, the use of personalized genomics is broken down into countless applications which are keeping the market on the forefront of innovation while trying to fulfil the need for individualized treatment across many industries.
Personalized Genomics Market Regional Insights:
North America is expected to be the largest market for the global personalized genomics market
North America is identified as the largest market in the global Personalized Genomics Market due to factors that include well-developed healthcare services, increased spending on the development of biotechnology and genomic systems, and a large number of firms that offer personalized Genomics services. The region has long been presented with a favourable legal environment as regards the commercialization of genetic testing services and therapies as well as innovation. Further, awareness regarding the field of personalised medicine among both, the healthcare providers and the customers is creating a strong demand for genomic solutions with treatment plans that are customized for the individual. The continued active involvement of key players and constant partnership between academic institutions and industry additionally strengthen North America’s position in this constantly developing market positioning the region at the forefront of the personalized genomics advancements.
Active Key Players in the Personalized Genomics Market:
23andMe (U.S.)
Mapmygenome (India)
Invitea (India)
Genetic Technology Limited (Australia)
Lonza (Switzerland)
Interleukin Genetics, Inc. (U.S.)
GNA Genotek (Canada)
Helix (U.S.)
MyHeritage (Israel)
Pathway Genomics (U.S.)
Veritas Genetics (U.S.)
Xcode (U.S.)
Color Genomics (U.S.)
Myriad Genetics (U.S.)
Quest Diagnostics (U.S.)
Bio-Rad Laboratories, Inc. (U.S.)
Illumina (U.S.)
Thermo Fisher Scientific (U.S.)
Qiagen (Germany)
Genomic Health (U.S.)
Nebula Genomics (U.S.)
Others Active Players.
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Challenges
3.2 Market Trend Analysis
3.3 PESTLE Analysis
3.4 Porter’s Five Forces Analysis
3.5 Industry Value Chain Analysis
3.6 Ecosystem
3.7 Regulatory Landscape
3.8 Price Trend Analysis
3.9 Patent Analysis
3.10 Technology Evolution
3.11 Investment Pockets
3.12 Import-Export Analysis
Chapter 4: Personalized Genomics Market by Test Type
4.1 Personalized Genomics Market Snapshot and Growth Engine
4.2 Personalized Genomics Market Overview
4.3 Oncology Testing
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.3.3 Key Market Trends, Growth Factors and Opportunities
4.3.4 Oncology Testing: Geographic Segmentation Analysis
4.4 Infectious Disease Testing
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.4.3 Key Market Trends, Growth Factors and Opportunities
4.4.4 Infectious Disease Testing: Geographic Segmentation Analysis
4.5 Neurological Testing
4.5.1 Introduction and Market Overview
4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.5.3 Key Market Trends, Growth Factors and Opportunities
4.5.4 Neurological Testing: Geographic Segmentation Analysis
4.6 Cardiovascular Testing
4.6.1 Introduction and Market Overview
4.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.6.3 Key Market Trends, Growth Factors and Opportunities
4.6.4 Cardiovascular Testing: Geographic Segmentation Analysis
4.7 Others
4.7.1 Introduction and Market Overview
4.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.7.3 Key Market Trends, Growth Factors and Opportunities
4.7.4 Others: Geographic Segmentation Analysis
Chapter 5: Personalized Genomics Market by Technology
5.1 Personalized Genomics Market Snapshot and Growth Engine
5.2 Personalized Genomics Market Overview
5.3 PCR-based Tests
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 PCR-based Tests: Geographic Segmentation Analysis
5.4 Microarray-based Tests
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Microarray-based Tests: Geographic Segmentation Analysis
5.5 Sequencing-based Tests
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Sequencing-based Tests: Geographic Segmentation Analysis
5.6 Others)
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.6.3 Key Market Trends, Growth Factors and Opportunities
5.6.4 Others): Geographic Segmentation Analysis
5.7 Application (Diagnostics
5.7.1 Introduction and Market Overview
5.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.7.3 Key Market Trends, Growth Factors and Opportunities
5.7.4 Application (Diagnostics: Geographic Segmentation Analysis
5.8 Precision Medicine
5.8.1 Introduction and Market Overview
5.8.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.8.3 Key Market Trends, Growth Factors and Opportunities
5.8.4 Precision Medicine: Geographic Segmentation Analysis
5.9 Wellness
5.9.1 Introduction and Market Overview
5.9.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.9.3 Key Market Trends, Growth Factors and Opportunities
5.9.4 Wellness: Geographic Segmentation Analysis
5.10 Reproductive Health
5.10.1 Introduction and Market Overview
5.10.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.10.3 Key Market Trends, Growth Factors and Opportunities
5.10.4 Reproductive Health: Geographic Segmentation Analysis
5.11 Sports Nutrition & Health Lifestyle
5.11.1 Introduction and Market Overview
5.11.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.11.3 Key Market Trends, Growth Factors and Opportunities
5.11.4 Sports Nutrition & Health Lifestyle: Geographic Segmentation Analysis
5.12 Others)
5.12.1 Introduction and Market Overview
5.12.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.12.3 Key Market Trends, Growth Factors and Opportunities
5.12.4 Others): Geographic Segmentation Analysis
5.13 End User (Hospitals & Clinics
5.13.1 Introduction and Market Overview
5.13.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.13.3 Key Market Trends, Growth Factors and Opportunities
5.13.4 End User (Hospitals & Clinics: Geographic Segmentation Analysis
5.14 Research Centers
5.14.1 Introduction and Market Overview
5.14.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.14.3 Key Market Trends, Growth Factors and Opportunities
5.14.4 Research Centers: Geographic Segmentation Analysis
5.15 Pharmaceutical & Biotechnology Companies
5.15.1 Introduction and Market Overview
5.15.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.15.3 Key Market Trends, Growth Factors and Opportunities
5.15.4 Pharmaceutical & Biotechnology Companies: Geographic Segmentation Analysis
5.16 Diagnostic Laboratories
5.16.1 Introduction and Market Overview
5.16.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.16.3 Key Market Trends, Growth Factors and Opportunities
5.16.4 Diagnostic Laboratories: Geographic Segmentation Analysis
5.17 Others
5.17.1 Introduction and Market Overview
5.17.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.17.3 Key Market Trends, Growth Factors and Opportunities
5.17.4 Others: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Personalized Genomics Market Share by Manufacturer (2023)
6.1.3 Industry BCG Matrix
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 23ANDME (U.S.)
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Role of the Company in the Market
6.2.5 Sustainability and Social Responsibility
6.2.6 Operating Business Segments
6.2.7 Product Portfolio
6.2.8 Business Performance
6.2.9 Key Strategic Moves and Recent Developments
6.2.10 SWOT Analysis
6.3 MAPMYGENOME (INDIA)
6.4 INVITEA (INDIA)
6.5 GENETIC TECHNOLOGY LIMITED (AUSTRALIA)
6.6 LONZA (SWITZERLAND)
6.7 INTERLEUKIN GENETICS INC. (U.S.)
6.8 GNA GENOTEK (CANADA)
6.9 HELIX (U.S.)
6.10 MYHERITAGE (ISRAEL)
6.11 PATHWAY GENOMICS (U.S.)
6.12 VERITAS GENETICS (U.S.)
6.13 XCODE (U.S.)
6.14 COLOR GENOMICS (U.S.)
6.15 MYRIAD GENETICS (U.S.)
6.16 QUEST DIAGNOSTICS (U.S.)
6.17 BIO-RAD LABORATORIES INC. (U.S.)
6.18 ILLUMINA (U.S.)
6.19 THERMO FISHER SCIENTIFIC (U.S.)
6.20 QIAGEN (GERMANY)
6.21 GENOMIC HEALTH (U.S.)
6.22 NEBULA GENOMICS (U.S.)
6.23 OTHER ACTIVE PLAYERS
Chapter 7: Global Personalized Genomics Market By Region
7.1 Overview
7.2. North America Personalized Genomics Market
7.2.1 Key Market Trends, Growth Factors and Opportunities
7.2.2 Top Key Companies
7.2.3 Historic and Forecasted Market Size by Segments
7.2.4 Historic and Forecasted Market Size By Test Type
7.2.4.1 Oncology Testing
7.2.4.2 Infectious Disease Testing
7.2.4.3 Neurological Testing
7.2.4.4 Cardiovascular Testing
7.2.4.5 Others
7.2.5 Historic and Forecasted Market Size By Technology
7.2.5.1 PCR-based Tests
7.2.5.2 Microarray-based Tests
7.2.5.3 Sequencing-based Tests
7.2.5.4 Others)
7.2.5.5 Application (Diagnostics
7.2.5.6 Precision Medicine
7.2.5.7 Wellness
7.2.5.8 Reproductive Health
7.2.5.9 Sports Nutrition & Health Lifestyle
7.2.5.10 Others)
7.2.5.11 End User (Hospitals & Clinics
7.2.5.12 Research Centers
7.2.5.13 Pharmaceutical & Biotechnology Companies
7.2.5.14 Diagnostic Laboratories
7.2.5.15 Others
7.2.6 Historic and Forecast Market Size by Country
7.2.6.1 US
7.2.6.2 Canada
7.2.6.3 Mexico
7.3. Eastern Europe Personalized Genomics Market
7.3.1 Key Market Trends, Growth Factors and Opportunities
7.3.2 Top Key Companies
7.3.3 Historic and Forecasted Market Size by Segments
7.3.4 Historic and Forecasted Market Size By Test Type
7.3.4.1 Oncology Testing
7.3.4.2 Infectious Disease Testing
7.3.4.3 Neurological Testing
7.3.4.4 Cardiovascular Testing
7.3.4.5 Others
7.3.5 Historic and Forecasted Market Size By Technology
7.3.5.1 PCR-based Tests
7.3.5.2 Microarray-based Tests
7.3.5.3 Sequencing-based Tests
7.3.5.4 Others)
7.3.5.5 Application (Diagnostics
7.3.5.6 Precision Medicine
7.3.5.7 Wellness
7.3.5.8 Reproductive Health
7.3.5.9 Sports Nutrition & Health Lifestyle
7.3.5.10 Others)
7.3.5.11 End User (Hospitals & Clinics
7.3.5.12 Research Centers
7.3.5.13 Pharmaceutical & Biotechnology Companies
7.3.5.14 Diagnostic Laboratories
7.3.5.15 Others
7.3.6 Historic and Forecast Market Size by Country
7.3.6.1 Russia
7.3.6.2 Bulgaria
7.3.6.3 The Czech Republic
7.3.6.4 Hungary
7.3.6.5 Poland
7.3.6.6 Romania
7.3.6.7 Rest of Eastern Europe
7.4. Western Europe Personalized Genomics Market
7.4.1 Key Market Trends, Growth Factors and Opportunities
7.4.2 Top Key Companies
7.4.3 Historic and Forecasted Market Size by Segments
7.4.4 Historic and Forecasted Market Size By Test Type
7.4.4.1 Oncology Testing
7.4.4.2 Infectious Disease Testing
7.4.4.3 Neurological Testing
7.4.4.4 Cardiovascular Testing
7.4.4.5 Others
7.4.5 Historic and Forecasted Market Size By Technology
7.4.5.1 PCR-based Tests
7.4.5.2 Microarray-based Tests
7.4.5.3 Sequencing-based Tests
7.4.5.4 Others)
7.4.5.5 Application (Diagnostics
7.4.5.6 Precision Medicine
7.4.5.7 Wellness
7.4.5.8 Reproductive Health
7.4.5.9 Sports Nutrition & Health Lifestyle
7.4.5.10 Others)
7.4.5.11 End User (Hospitals & Clinics
7.4.5.12 Research Centers
7.4.5.13 Pharmaceutical & Biotechnology Companies
7.4.5.14 Diagnostic Laboratories
7.4.5.15 Others
7.4.6 Historic and Forecast Market Size by Country
7.4.6.1 Germany
7.4.6.2 UK
7.4.6.3 France
7.4.6.4 The Netherlands
7.4.6.5 Italy
7.4.6.6 Spain
7.4.6.7 Rest of Western Europe
7.5. Asia Pacific Personalized Genomics Market
7.5.1 Key Market Trends, Growth Factors and Opportunities
7.5.2 Top Key Companies
7.5.3 Historic and Forecasted Market Size by Segments
7.5.4 Historic and Forecasted Market Size By Test Type
7.5.4.1 Oncology Testing
7.5.4.2 Infectious Disease Testing
7.5.4.3 Neurological Testing
7.5.4.4 Cardiovascular Testing
7.5.4.5 Others
7.5.5 Historic and Forecasted Market Size By Technology
7.5.5.1 PCR-based Tests
7.5.5.2 Microarray-based Tests
7.5.5.3 Sequencing-based Tests
7.5.5.4 Others)
7.5.5.5 Application (Diagnostics
7.5.5.6 Precision Medicine
7.5.5.7 Wellness
7.5.5.8 Reproductive Health
7.5.5.9 Sports Nutrition & Health Lifestyle
7.5.5.10 Others)
7.5.5.11 End User (Hospitals & Clinics
7.5.5.12 Research Centers
7.5.5.13 Pharmaceutical & Biotechnology Companies
7.5.5.14 Diagnostic Laboratories
7.5.5.15 Others
7.5.6 Historic and Forecast Market Size by Country
7.5.6.1 China
7.5.6.2 India
7.5.6.3 Japan
7.5.6.4 South Korea
7.5.6.5 Malaysia
7.5.6.6 Thailand
7.5.6.7 Vietnam
7.5.6.8 The Philippines
7.5.6.9 Australia
7.5.6.10 New Zealand
7.5.6.11 Rest of APAC
7.6. Middle East & Africa Personalized Genomics Market
7.6.1 Key Market Trends, Growth Factors and Opportunities
7.6.2 Top Key Companies
7.6.3 Historic and Forecasted Market Size by Segments
7.6.4 Historic and Forecasted Market Size By Test Type
7.6.4.1 Oncology Testing
7.6.4.2 Infectious Disease Testing
7.6.4.3 Neurological Testing
7.6.4.4 Cardiovascular Testing
7.6.4.5 Others
7.6.5 Historic and Forecasted Market Size By Technology
7.6.5.1 PCR-based Tests
7.6.5.2 Microarray-based Tests
7.6.5.3 Sequencing-based Tests
7.6.5.4 Others)
7.6.5.5 Application (Diagnostics
7.6.5.6 Precision Medicine
7.6.5.7 Wellness
7.6.5.8 Reproductive Health
7.6.5.9 Sports Nutrition & Health Lifestyle
7.6.5.10 Others)
7.6.5.11 End User (Hospitals & Clinics
7.6.5.12 Research Centers
7.6.5.13 Pharmaceutical & Biotechnology Companies
7.6.5.14 Diagnostic Laboratories
7.6.5.15 Others
7.6.6 Historic and Forecast Market Size by Country
7.6.6.1 Turkiye
7.6.6.2 Bahrain
7.6.6.3 Kuwait
7.6.6.4 Saudi Arabia
7.6.6.5 Qatar
7.6.6.6 UAE
7.6.6.7 Israel
7.6.6.8 South Africa
7.7. South America Personalized Genomics Market
7.7.1 Key Market Trends, Growth Factors and Opportunities
7.7.2 Top Key Companies
7.7.3 Historic and Forecasted Market Size by Segments
7.7.4 Historic and Forecasted Market Size By Test Type
7.7.4.1 Oncology Testing
7.7.4.2 Infectious Disease Testing
7.7.4.3 Neurological Testing
7.7.4.4 Cardiovascular Testing
7.7.4.5 Others
7.7.5 Historic and Forecasted Market Size By Technology
7.7.5.1 PCR-based Tests
7.7.5.2 Microarray-based Tests
7.7.5.3 Sequencing-based Tests
7.7.5.4 Others)
7.7.5.5 Application (Diagnostics
7.7.5.6 Precision Medicine
7.7.5.7 Wellness
7.7.5.8 Reproductive Health
7.7.5.9 Sports Nutrition & Health Lifestyle
7.7.5.10 Others)
7.7.5.11 End User (Hospitals & Clinics
7.7.5.12 Research Centers
7.7.5.13 Pharmaceutical & Biotechnology Companies
7.7.5.14 Diagnostic Laboratories
7.7.5.15 Others
7.7.6 Historic and Forecast Market Size by Country
7.7.6.1 Brazil
7.7.6.2 Argentina
7.7.6.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
Q1: What would be the forecast period in the Personalized Genomics Market research report?
A1: The forecast period in the Personalized Genomics Market research report is 2024-2032.
Q2: Who are the key players in the Personalized Genomics Market?
A2: 23andMe (U.S.), Mapmygenome (India), Invitea (India), Genetic Technology Limited (Australia), Lonza (Switzerland), Interleukin Genetics, Inc. (U.S.), GNA Genotek (Canada), Helix (U.S.), MyHeritage (Israel), Pathway Genomics (U.S.), Veritas Genetics (U.S.), Xcode (U.S.), Color Genomics (U.S.), Myriad Genetics (U.S.), Quest Diagnostics (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Illumina (U.S.), Thermo Fisher Scientific (U.S.), Qiagen (Germany), Genomic Health (U.S.), Nebula Genomics (U.S.), and Other Active Players.
Q3: What are the segments of the Personalized Genomics Market?
A3: The Personalized Genomics Market is segmented into By Test Type, Technology Application, End User and region. By Test Type, the market is categorized into Oncology Testing, Infectious Disease Testing, Neurological Testing, Cardiovascular Testing, and Others, By Technology, the market is categorized into PCR-based Tests, Microarray-based Tests, Sequencing-based Tests, and Others. By Application, the market is categorized into Diagnostics, Precision Medicine, Wellness, Reproductive Health, Sports Nutrition & Health Lifestyle, and Others. By End User, the market is categorized into Hospitals & Clinics, Research Centers, Pharmaceutical & Biotechnology Companies, Diagnostic Laboratories, and Others. By region, it is analyzed across North America (U.S., Canada, Mexico), Eastern Europe (Russia, Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe), Western Europe (Germany, UK, France, Netherlands, Italy, Spain, Rest of Western Europe), Asia Pacific (China, India, Japan, South Korea, Malaysia, Thailand, Vietnam, The Philippines, Australia, New Zealand, Rest of APAC), Middle East & Africa (Turkiye, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa), South America (Brazil, Argentina, Rest of SA).
Q4: What is the Personalized Genomics Market?
A4: Personalized genomics refers to the field of genomics that focuses on tailoring medical treatment and healthcare decisions to an individual's genetic makeup. This approach utilizes genetic information obtained through various testing methods to provide insights into a person's predisposition to certain diseases, their response to specific medications, and other health-related traits. By integrating genomic data with clinical information, personalized genomics aims to enhance the effectiveness of treatments, optimize drug dosages, and improve overall patient outcomes. This evolving discipline is increasingly being applied in areas such as oncology, pharmacogenomics, and preventive medicine, allowing healthcare providers to deliver more precise and individualized care based on a patient's unique genetic profile.
Q5: How big is the Personalized Genomics Market?
A5: Personalized Genomics Market Size Was Valued at USD 9.25 Billion in 2023, and is Projected to Reach USD 27.90 Billion by 2032, Growing at a CAGR of 17.19% From 2024-2032.
How to Buy a Report from eminsights.jp
On the product page, choose the license you want: Single-User License, Multi-User License or Enterprise License.
If you required report in your native language, then you can click on Translated Report button and fill out the form with report name and language you want, then our team will contact you as soon as possible.
Click the Buy Now button.
You will be redirected to the checkout page. Enter your company details and payment information.
Click Place Order to complete the purchase.
Confirmation: You’ll receive an order confirmation and our team will contact you shortly with your ordered report.
If you have any questions, fill out the contact form below or email us at bizdev@eminsights.net.
Thank you for choosing eminsights.jp!
